Current filters:

Keryx Biopharmaceuticals

Keryx Biopharma files for EU approval of Zerenex

Keryx Biopharma files for EU approval of Zerenex


US drugmaker Keryx Biopharmaceuticals has submitted a Marketing Authorization Application to the European…

EuropeKeryx BiopharmaceuticalsNephrology and HepatologyPharmaceuticalRegulationZerenex

US nephrologists views on prescribing Roche’s Mircera


Among surveyed US nephrologists, familiarity with Swiss drug major Roche's Mircera is low, but is still…

InjectaferKeryx BiopharmaceuticalsMirceraNeurologicalNorth AmericaPharmaceuticalRocheZerenex

Keryx Biopharma files for US approval of Zerenex


Keryx Biopharmaceuticals (Nasdaq: KERX) says it has submitted a New Drug Application to the US Food and…

BiotechnologyKeryx BiopharmaceuticalsNephrology and HepatologyNorth AmericaRegulationZerenex

Keryx Biopharma rockets on new Zerenex data and plans to file for approval


USA-based Keryx Biopharmaceuticals (Nasdaq: KERX) saw its shares close up a whopping 77% to $4.70 in…

BiotechnologyKeryx BiopharmaceuticalsNephrology and HepatologyPharmaceuticalRegulationRenagelRenvelaResearchSanofiZerenex

AEterna Zentaris and Keryx shares tank as cancer drug flops in Ph III


Canadian drug developer AEterna Zentaris (TSX: AEZ) and US licensee Keryx Pharmaceutical (Nasdaq: KERX)…

AEterna ZentarisKeryx BiopharmaceuticalsLicensingNephrology and HepatologyOncologyperifosinePharmaceuticalResearchZerenex

Drug manufacturing industry on an explosive journey, new study notes, highlighting Abbott and Keryx


It is needless to say that the drug manufacturing is a multi-billion dollar industry that is set to experience…

Abbott LaboratoriesFinancialKeryx BiopharmaceuticalsMergers & AcquisitionsPharmaceutical

Back to top